SCOTT DORN: Open Payments
NPI 1275850158 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,733 in 78 payments from 26 companies in 2025. Trend: 2023 $1,764 · 2024 $1,309 · 2025 $1,733
Food & beverage: $1,733
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $226 |
| PFIZER INC. | 14 | $197 |
| ABBVIE INC. | 8 | $181 |
| Novo Nordisk Inc | 7 | $165 |
| GlaxoSmithKline, LLC. | 6 | $143 |
| Antares Pharma, Inc. | 6 | $112 |
| Sumitomo Pharma America, Inc. | 4 | $102 |
| Amgen Inc. | 2 | $59 |
| Boston Scientific Corporation | 2 | $50 |
| Lilly USA, LLC | 3 | $46 |
Products named: AIRSUPRA, NURTEC ODT, XYOSTED, SHINGRIX, GEMTESA, Wegovy, QULIPTA, KRYSTEXXA.
Industry payments across CO — which companies pay providers there.
